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BACKGROUND AND PURPOSE 
The immune system plays important roles in driving the acute inflammatory response following 
myocardial ischemia/reperfusion injury (MIRI). Interleukin-21 (IL-21) is a pleiotropic cytokine 
with multiple immunomodulatory effects and its role in MIRI remains unknown. 
EXPERIMENTAL APPROACH 
Myocardial injury, neutrophil infiltration and expressions of neutrophil chemokines KC (CXCL1) 
and MIP-2 (CXCL2) were studied in a mouse model of MIRI. Effects of IL-21 on the expression 
of KC and MIP-2 in neonatal mouse cardiomyocytes (CMs) and cardiac fibroblasts (CFs) were 
determined by real-time PCR and ELISA. The signaling mechanisms underlying these effects 
were explored by western blotting.  
KEY RESULTS 
IL-21 was elevated within the acute phase of murine MIRI. Neutralization of IL-21 attenuated 
myocardial injury, as illustrated by reduced infarct size, decreased cardiac troponin T levels and 
improved cardiac function, whereas exogenous IL-21 administration exerted opposite effects. 
IL-21 increased the presence of cardiac-infiltrating neutrophil and increased myocardial 
expression of KC and MIP-2 following MIRI. Moreover, neutrophil depletion attenuated the 
IL-21-induced myocardial injury. Mechanistically, IL-21 was found to induce the production of 
KC and MIP-2 in neonatal CMs and CFs, and it enhanced neutrophil migration as revealed by a 
migration assay. Furthermore, we demonstrated that IL-21-mediated chemokine expression 
involved the activation of Akt/NF-kB signaling in CMs and p38 MAPK/NF-kB signaling in CFs. 
CONCLUSIONS AND IMPLICATIONS 
Our data provide novel evidence that IL-21 plays a pathogenic role in MIRI, most likely by 
promoting cardiac neutrophil infiltration. Therefore, targeting IL-21 may hold therapeutic 
potential in treating MIRI. 
Key words: Interleukin-21; ischemia/reperfusion injury; inflammation; neutrophil 
Abbreviations: AMI, Acute myocardial infarction; CF, cardiac fibroblast; CM, cardiomyocyte; 
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KC, keratinocyte-derived chemokine (CXCL1); MIP-2, macrophage inflammatory protein-2 
(CXCL2); MIRI, myocardial ischemia/reperfusion injury; STAT, signal transducers and 
activators of transcription 
Running Title: IL-21 promotes MIRI via neutrophil recruitment 




Acute myocardial infarction (AMI) is one of the leading causes of death worldwide. Early 
reperfusion after coronary artery occlusion is the most effective strategy to protect the vulnerable 
myocardium and limit infarct size. However, a variety of alterations occurring at the time of 
blood flow restoration may paradoxically exert deleterious effects and result in additional injury, 
which is referred to as myocardial ischemia/reperfusion injury (MIRI). Numerous 
pathophysiological mechanisms are involved in MIRI, including calcium overload, dissipation of 
the mitochondrial membrane potential, free radical formation, endothelial dysfunction, platelet 
aggregation and microembolization (Turer and Hill, 2010). Furthermore, there is a growing 
appreciation of the role of immune activation in the pathogenesis of myocardial damage after 
reperfusion (Timmers et al., 2012; Hofmann and Frantz, 2015).  
Interleukin-21 (IL-21) is a type-I cytokine produced primarily by CD4+ T cell populations 
and natural killer (NK) T cells, as well as by CD8+ T cells and gamma delta (γδ) T cells (Sutton 
et al.,2009; Spolski and Leonard, 2014). IL-21 exerts broad immunomodulatory effects and is 
implicated in antitumor and antiviral responses, as well as in inflammatory responses, where it 
promotes the development of autoimmune diseases and certain inflammatory disorders 
(Parrish-Novak et al., 2000; Spolski and Leonard, 2008). IL-21 signals through a heterodimeric 
receptor complex formed by its unique receptor IL-21R and the common cytokine receptor 
gamma chain, γc. IL-21R is widely expressed by immune cells, including T cells, B cells, NK 
cells, NKT cells, dendritic cells, macrophages and neutrophils (Spolski et al., 2014). More 
recently, the expression of IL-21R was also described in non-immune cells, such as epithelial 
cells (Caruso et al., 2007a; Caruso et al., 2007b), fibroblasts (Jungel et al., 2004; Monteleone et 
al., 2006), keratinocytes (Caruso et al., 2009; Distler et al., 2005), endothelial cells (Wang et al., 
2015), and neurons (Clarkson et al., 2014; Tzartos et al., 2011), suggesting the possibility that 
IL-21 may modulate additional inflammatory pathways besides its regulatory effects on humoral 
and cellular immunity. Recent findings suggest an early elevation of IL-21 following liver IRI in 
mice, which may be partially responsible for NK cell-mediated liver injury (Feng et al., 2012). 
Clarkson et al. reported that in a mouse model of transient focal brain ischemia, IL-21 was 
highly up-regulated in ischemic brain tissues and played a pathogenic role (Clarkson et al., 2014). 
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However, potential implications of IL-21 in relation to MIRI are still far from complete. 
In this study, we demonstrated that IL-21 was elevated during the acute phase following 
MIRI. CD4+ T cells were a major source of IL-21 production. Neutralization of endogenous 
IL-21 protected against myocardial injury, whereas exogenous IL-21 administration aggravated 
myocardial injury. IL-21 increased the infiltration of neutrophil following MIRI and increased 
myocardial expression of CXC chemokines keratinocyte-derived chemokine (KC) and 
macrophage inflammatory protein-2 (MIP-2). Depletion of neutrophil abrogated the 
IL-21-induced myocardial injury. Furthermore, IL-21 directly increased the expression of KC 
and MIP-2 in cardiomyocytes (CMs) and cardiac fibroblasts (CFs) in vitro. The potential 
signaling mechanisms underlying these responses may involve the Akt, p38 MAPK, and NF-kB 
signaling pathways.  
Methods 
Animal model and treatments 
Animal studies are reported in accordance with the ARRIVE guidelines (Kilkenny et al., 
2010; McGrath and Lilley, 2015). Male C57BL/6 mice aged 8-12 weeks (weight 20-24g) were 
purchased from Wuhan University (Wuhan, China), and maintained on a chow diet in a 12-hour 
light/12-hour dark environment at 25 °C in the Tongji Medical School Animal Care Facility. The 
treatment and care of studied animals were approved by the Animal Care and Utilization 
Committee of Huazhong University of Science and Technology. The experimental procedures 
used in the work were as humane as possible. A murine MIRI model was established by 
temporary occlusion of the left anterior descending (LAD) coronary artery as previously 
described (Bohl et al., 2009; Michael et al., 1995; Tarnavski et al., 2004). Briefly, mice were 
anesthetized by intraperitoneal injection of ketamine (50 mg·kg-1) and pentobarbital sodium (50 
mg·kg-1) and ventilated through a rodent respirator. The adequacy of anesthesia was assessed by 
testing corneal reflexes and motor responses to tail pinch. Hearts were exposed by left 
thoracotomy and LAD was visualized and ligated using 6-0 suture around fine PE-10 tubing with 




For the measurement of IL-21/IL-21R expression patterns, C57BL/6 mice were randomly 
subjected to a sham procedure or to 30 minutes of ischemia followed by 30 min or 1, 6, 12, or 24 
hours of reperfusion (n=6 per group). To elucidate the causative role of IL-21 in this process, 
mice were randomly assigned to four groups. In the (1) anti-IL-21 treatment group (anti-IL-21, 
n=9) and the (2) isotype control antibody treatment group (isotype, n=9), mice were i.v. with 0.2 
ml PBS, 100 μg of anti-IL-21 neutralizing mAb or an isotype control mAb 5 min prior to 
reperfusion. In the (3) recombinant mouse-IL-21 treatment group (IL-21, n=10) and the (4) 
vehicle treatment group (vehicle, n=11), mice were i.v. with 0.2 ml PBS containing 0.5% bovine 
serum albumin or 1 μg of recombinant mouse IL­21 diluted in 0.2 ml PBS containing 0.5% 
bovine serum albumin 5 min prior to reperfusion. For the neutrophil depletion study, the mice 
were randomly divided into five groups: (1) the PBS treatment group (n=5), (2) the isotype 
control mAb treatment group (n=5), (3) the anti-Ly6G mAb treatment group (n=5), (4) the 
isotype control mAb with IL-21 treatment group (n=5), and (5) the anti-Ly6G mAb with IL-21 
treatment group (n=5). 250 μg of isotype control mAb or anti-Ly6G mAb dissolved in 0.2 ml 
PBS was i.p. one day before surgery. 1 μg of recombinant mouse IL­21 was injected 
intravenously 5 min prior to reperfusion. 
Echocardiographic analysis of cardiac function  
At the end of a 1-day reperfusion period, mice were anesthetized with inhaled 2% 
isoflurane/oxygen mixture and two-dimensional echocardiographic views of the mid-ventricular 
short axis and the parasternal long axes were obtained using a Vevo 2100 high-resolution 
microimaging system (VisualSonics, Toronto, Ontario, Canada) by a technician who was blinded 
to treatment groups. Left ventricular ejection fraction (EF) and fractional shortening (FS) were 
calculated from the digital images using a standard formula as previously described (Li et al., 
2007) .  
Serum troponin T 
Blood concentrations of troponin T (cTnT) were measured as an index of cardiac cellular 
damage using a quantitative rapid assay kit (Roche Diagnostics GmbH, Mannheim, Germany) as 
previously described (Metzler et al., 2001).  
Measurement of area at risk and infarct size 
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Infarct size after MIRI was determined as previously described (Bohl et al., 2009; Michael 
et al., 1995). Briefly, after 24 h of reperfusion, mice were anesthetized and the LAD was 
re-occluded at the previous ligation. 1% Evans blue was injected, and the heart was quickly 
excised, frozen, and cut into transverse sections below the ligature. These sections were then 
incubated with 1% 2,3,5-triphenyltetrazolium chloride (TTC) solution. Left ventricular area (LV), 
area at risk (AAR) and infarct area (I) were analyzed as described (Bohl et al., 2009) using 
Image-Pro Plus 6.0 software. The measurement was carried out by an investigator who was 
blinded to the experimental groups. 
Heart-infiltrating cell isolation and flow cytometry analysis 
Heart-infiltrating leukocytes were isolated as previously described, with some modifications 
(Liao et al., 2012). Briefly, following euthanasia by cervical dislocation, ischemic tissue was 
excised and single-cell suspensions were obtained via the digestion of ischemic myocardium 
with 0.1% collagenase B solution. Thereafter, granulocytes were enriched through density 
gradient centrifugation using Ficoll (Histopaque-1119). For the analysis of neutrophil infiltration 
in ischemic tissue, the cells were labeled with PE-cy7 anti-mouse CD11b and PE anti-mouse 
Ly-6G/Gr-1. For the analysis of IL-21-secreting leucocytes, the cells were labeled with FITC 
anti-mouse CD45, PE anti-mouse IL-21, Percp-cy5.5 anti-mouse CD3, PE-cy7 anti-mouse CD4 
and APC anti-mouse γδTCR. Stained cells were measured via FACS Calibur flow cytometry 
(BD Biosciences, San Jose, CA, USA), and data were analyzed using CellQuest software (BD 
Biosciences) by a technician who was blinded to treatment groups. Caltag Counting Beads 
(Invitrogen Life Technologies, USA) were used to calculate the absolute number of cells. 
Cell isolation and culture 
Neonatal cardiomyocytes (CMs) were isolated from ventricles of 1-day-old C57BL/6 mice 
using previously described methods with some modifications (Rui et al., 2001). Briefly, neonatal 
mice were euthanized by cervical dislocation and their ventricles were minced and digested with 
Liberase TH (0.1 U·mL-1 in Hanks’ balanced salt solution (HBSS)). After being filtered through a 
nylon cell strainer (70 μm size, BD Falcon, Franklin Lakes, NJ), the collected cells were 
incubated in 5% CO2 at 37°C for 1 hour. Cardiac fibroblasts (CFs) were separated from CMs via 
differential plating, during which CMs did not attach to the culture flasks. The cells were then 
separately cultured with high-glucose DMEM cell culture containing 10% fetal bovine serum, 
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1% penicillin and streptomycin. CMs were used in experiments after they had formed a 
confluent monolayer and were contracting in synchrony at 72 hours. CFs from passages 2 and 3 
were used for the experiment.  
Neutrophils were isolated from the marrow of the femurs and tibias of adult mice through 
density gradient centrifugation as previously described (Lowell et al., 1996; Siemsen et al., 
2007). Briefly, following euthanasia by cervical dislocation, the long bones of the hind legs were 
removed, and the ends were clipped. The bone marrow cells were flushed from the tibias and 
femurs with HBSS and filtered through a cell strainer (40 µm size, BD Falcon). The suspension 
was subject to a Percoll (GE Healthcare, Sweden) step gradient. Cells were collected from the 
neutrophil-enriched fraction, followed by a further isolation with Histopaque 1119. Purity of 
neutrophils was evaluated by flow cytometry (Ly-6G/Gr-1 and CD11b double-positive 
cells >85%). 
ELISA  
Levels of KC and MIP-2 in the conditioned supernatant were quantified using commercial 
ELISA kits (R&D	 Systems, Minneapolis, MN, USA) according to the manufacturer’s 
instructions. The absorbance of each well was determined at 450 nm using a microplate reader 
(Elx800, Bio-Tek, USA). 
Neutrophil migration assays  
Neutrophil migration was measured using transwell inserts with polycarbonate filter (5-μm 
pores, Corning, New York, USA) preloaded in 24-well tissue culture plates. Freshly isolated 
neutrophils (1×106 cells) were added to the upper chambers of the transwell inserts, and 
conditioned supernatants from CMs or CFs were added to the lower well. After 60 min of 
incubation, the number of migrated neutrophils in the lower chamber was counted in five 
randomly chosen fields using an inverted microscope (Ruddy et al., 2004). The analysis was 
carried out by an investigator who was blinded to the experimental groups. 
Quantitative RT-PCR (qRT-PCR)  
Total RNA was extracted from ischemic tissue or cells using Trizol (Invitrogen, Carlsbad, 
CA, USA) and reverse transcribed into cDNA using the PrimeScript RT reagent kit (Takara 
Biotechnology, Dalian, China) according to the manufacturer’s instructions. The mRNA levels of 
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the target genes were quantified using SYBR Green Master Mix (Takara Biotechnology, Dalian, 
China) with the CFX96 Real-Time PCR Detection System (Bio-Rad, Berkeley, CA, USA). Data 
from each sample were normalized to β-actin. The primer sequences are shown in Supporting 
Information Table S1. 
Western blotting  
Protein extracted from tissues or cells was separated on 10-12% sodium dodecyl sulfate 
(SDS)-polyacrylamide electrophoresis gels and transferred to polyvinylidene difluoride 
membranes. After being blocked with 5% skimmed milk in Tris-buffered saline (TBS)(1×) for 2 
hours, the membranes were incubated with indicated primary antibodies at 4°C overnight, 
followed by incubation with HRP-conjugated secondary antibody for 2 hours. The specific bands 
were detected using the Super ECL reagent (Pierce, Rockford, IL). Images were obtained and 
analyzed using Image Lab 3.0 software. The intensity of the GAPDH band was used as a loading 
control for comparison between samples. 
Statistical analysis 
The data and statistical analysis in the present study comply with the recommendations on 
experimental design and analysis in pharmacology (Curtis et al., 2015). Data were collected and 
analyzed in a blinded manner. Data are presented as the means ± SEM. For normally distributed 
data, differences were evaluated using unpaired Student’s t test between two groups. When 
comparing ≥3 different groups, One-way ANOVA followed by Tukey post hoc test was used for 
multiple comparisons, and Dunnett post hoc test was used when comparing each group with a 
control, only if F reached significance and there was no significant variance inhomogeneity. All 
analyses were performed using SPSS 13.0 (SPSS, Chicago, IL), and statistical significance was 
set at P < 0.05 (two-tailed).   
Materials  
Anti-mouse IL-21 monoclonal antibody (clone: FFA21), isotype control antibody (clone: eBR2a), 
PE-cy7 anti-mouse CD11b, PE anti-mouse Ly-6G/Gr-1, FITC anti-mouse CD45, PE anti-mouse 
IL-21, Percp-cy5.5 anti-mouse CD3, PE-cy7 anti-mouse CD4 and APC anti-mouse γδTCR were 
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obtained from eBioscience (San Diego, CA, USA). Recombinant mouse-IL-21 and primary 
antibodies to mouse IL-21 and IL-21R were purchased from R&D Systems (Minneapolis, MN, 
USA). Anti-mouse anti-Ly6G monoclonal antibody (clone: 1A8) and isotype control antibody 
(clone: RTK2758) were obtained from Biolegend (San Diego, CA, USA). Recombinant murine 
TNF-α was purchased from PeproTech Inc. (Rocky Hill, NJ, USA). Evans blue, 
2,3,5-triphenyltetrazolium chloride (TTC), hydrogen peroxide (H2O2) solution, bovine serum 
albumin and Histopaque-1119 were purchased from Sigma-Aldrich (St. Louis, MO, USA). 
LY294002 and antibodies to phospho-Akt (Ser473), phospho-p38 (Thr180/Tyr182), 
phospho-ERK (Thr202/Tyr204), phospho-NF-kappa-B p65 (Ser536), phospho-Stat1 (Tyr701), 
phospho-Stat3 (Tyr705), Akt, p38 MAPK, ERK, NF-kappa-B p65, Stat1 and Stat3 were 
purchased from Cell Signaling Technology (Danvers, MA, USA). Antibody against GAPDH was 
purchased from AntGene (Wuhan,China). BAY11-7082 and SB203580 were obtained from 
Selleckchem (Houston, TX, USA). Collagenase B and Liberase TH was obtained from Roche 
Diagnostics GmbH (Mannheim, Germany). High-glucose DMEM, Hanks’ balanced salt solution 
(HBSS) and fetal bovine serum were purchased from GIBCO (Carlsbad, CA, USA). 
Results 
Increased expression of IL-21 and its receptor in the myocardium post-reperfusion 
We first examined the expression kinetics of IL-21 in the ischemic myocardium via quantitative 
real-time PCR. As illustrated in Figure 1A, mRNA expression of IL-21 increased rapidly within 
30 min after reperfusion, peaked at 6 h and remained elevated but with a declining trend for up to 
24 h. Likewise, protein expression of IL-21 was up-regulated as early as 30 min after reperfusion, 
reaching peak expression at 24 h (Figure 1B). Multiple cell types, including T cells, and innate 
immune cells, could produce IL-21 (Clarkson et al., 2014; Sutton et al., 2009). To determine 
which leucocytes account for the increase of IL-21 in the ischemic myocardium，we used 
intracellular cytokine staining combined with staining for some surface markers. Over 80% of 
the IL-21-secreting leukocytes were CD3+ T cells, including about 77% CD4+ cells and 1% 
γδTCR+ cells, indicating that CD4+ cells were the major source of IL-21 (Figure 1E).  
IL-21 exerts biological effects through binding to its receptor, a heterodimer of IL-21R and 
the common cytokine receptor γc. In the present study, we found that both mRNA and protein 
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expression levels of IL-21R were increased at 12 h (2.5±0.6-fold and 1.7±0.2-fold, respectively) 
and that they remained elevated until 24 h (4.0±0.4 and 1.8±0.2-fold, respectively) (Figure 1C 
and D). Furthermore, in our vitro study, we found that IL-21R gene expression in neonatal 
mouse CMs was increased at 1 h and reached a peak at 8 h after the induction of oxidative stress 
with H2O2. Meanwhile, the mRNA expression of IL-21R in CFs was increased at 4 h and reached 
a peak at 12 h after treated by TNF-α (Supporting Information Figure S1).  
Neutralization of endogenous IL-21 attenuates myocardial injury, whereas exogenous IL-21 
aggravates it 
The early up-regulation of IL-21 and its specific receptor IL-21R in post-ischemic myocardium 
indicates a potential role of IL-21 in MIRI. Therefore, we examined the functional significance 
of IL-21 on MIRI by treating mice with an anti-IL-21 neutralizing antibody or recombinant 
IL-21 before reperfusion. In comparison to the effects observed in isotype-treated mice, 
anti-IL-21 neutralizing antibody administration reduced infarct size decreased cTnT levels and 
restored cardiac function as shown by improved left ventricular ejection fraction (EF) and 
fractional shortening (FS). In contrast, exogenous IL-21 administration significantly increased 
infarct size, elevated cTnT levels, and reduced cardiac function in comparison to the effects 
observed in vehicle-treated mice. Collectively, these findings indicated that IL-21 played a 
pathogenic role in MIRI (Figure 2). 
IL-21 mediates neutrophil recruitment through the regulation of CXC chemokines in vivo 
Infiltrated inflammatory cells play key roles in the extension of myocardial ischemic injury. Of 
these cells, neutrophils are the predominant type that accumulates in the reperfused myocardium 
within the first hours after reperfusion (Yan et al., 2013; Dreyer et al., 1991). To determine 
whether IL-21 is involved in neutrophil recruitment in the context of MIRI, we analyzed the 
absolute counts and frequency of CD11b+Gr-1+ neutrophils infiltrating the ischemic myocardium 
3 h after reperfusion via flow cytometry. In comparison to infiltration in sham-operated mice, 
there was an obvious increase in neutrophil infiltration in the reperfused myocardium (I/R-mice). 
Moreover, exogenous IL-21 administration further increased neutrophil infiltration (Figure 
3A-3B), while anti-IL-21 neutralizing antibody treatment reduced neutrophil infiltration (Figure 
3C-3D). To examine whether neutrophils are directly related to the myocardial ischemic injury 
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after exogenous IL-21 administration, we conducted a neutrophil depletion study. After depletion 
of neutrophils by anti-Ly6G antibody, the number of neutrophils infiltrating the ischemic 
myocardium was markedly declined (Supporting Information Figure S2A). Furthermore, 
depletion of neutrophils in mice treated with exogenous IL-21 decreased infarct size, declined 
cTnT levels and improved cardiac function compared with isotype antibody group (Supporting 
Information Figure S2B-D). These results indicated that neutrophils were essential for 
IL-21-induced myocardial ischemic injury. 
ELR-containing CXC chemokines KC, MIP-2 and lipopolysaccharide-induced CXC chemokine 
(LIX) are reported to be potent neutrophil chemoattractants (Frangogiannis and Entman, 2005). 
Therefore, we further investigated the potential effects of IL-21 on the myocardial expression of 
these chemokines via real-time PCR. Relative to the effects in vehicle-treated mice, IL-21 
administration rapidly up-regulated KC and MIP-2 mRNA expression as early as 30 min after 
reperfusion. This elevation persisted for 3 h for MIP-2. However, no significant changes were 
observed in the expression of LIX (Figure 3E). In addition, the mRNA expression of KC and 
MIP-2 was reduced in the ischemic myocardium after neutralization of endogenous IL-21 
(Figure 3F).  
IL-21 promotes neutrophil migration and the expression of KC and MIP-2 in CMs and CFs 
To determine the direct effects of IL-21 on different cell types involved in this process, we 
isolated neutrophils from adult mouse bone marrow and prepared CM/CF primary cultures from 
neonatal mice. Neutrophil migration assays indicated an enhanced neutrophil migration in the 
presence of conditioned medium from CMs or CFs treated with IL-21, relative to the effects 
observed in the presence of conditioned medium from unstimulated cells (Figure 4A). We then 
examined the effects of IL-21 on the expression of KC/MIP-2 in CMs and CFs. As shown in 
Figure 4B, IL-21 up-regulated KC and MIP-2 mRNA expression in CMs and CFs. Moreover, as 
detected via ELISA, IL-21 also increased KC and MIP-2 secretion by both CMs and CFs (Figure 
4C).  
Signaling mechanisms underlying the effects of IL-21 
IL-21-mediated cellular effects have been reported to be associated with the ERK, p38 MAPK, 
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PI3K/Akt, NF-kB and STAT1/3 signaling pathways (Pelletier et al., 2004; Caruso et al., 2007a,b; 
de Totero et al., 2008; Xing et al., 2016), which are also involved in MIRI (Lopez-Neblina and 
Toledo-Pereyra, 2006). To further elucidate the mechanisms by which IL-21 affects MIRI, we 
focused on these signaling pathways. We first explored the time-course changes of these 
signaling pathways in the myocardium. We found that reperfusion increased the phosphorylation 
of ERK, p38 MAPK and NF-kB p65 as early as 10 min, while the activation of Akt, STAT1 and 
STAT3 occurred at 30 min after reperfusion (Supporting Information Figure S3). We further 
examined the effects of IL-21 on each signaling pathway at both 10 and 30 min after reperfusion. 
As shown in Figure 5, IL-21 further increased the phosphorylation of p38 MAPK at both 10 and 
30 min after reperfusion and enhanced NF-kB p65 activation at 30 min after reperfusion.  
To examine the direct effects of IL-21 on isolated CMs/CFs, we assessed the activation 
kinetics of the above-mentioned signaling pathways at a cellular level. As demonstrated in 
Figure 6, CMs and CFs responded to IL-21 with different signaling kinetics, suggesting a 
cell-type-specific response. In CMs, the phosphorylation of Akt was enhanced by IL-21 
administration at early time points (10-30 min), and it then returned to baseline at 1 h. NF-kB 
p65 phosphorylation was induced within 30 min of IL-21 administration and remained elevated 
for up to 2 h. Stimulation with IL-21 in CFs induced the activation of p38 MAPK signaling 
within 30 min, which remained elevated for 2 h. NF-kB p65 phosphorylation was induced at 1 h 
and was maintained for up to 2 h. However, the activity of Akt in IL-21-treated CFs presented an 
opposite trend in comparison to that observed in CMs, showing a slightly inhibited activity at 
30-60 min after IL-21 administration. There were no significant changes in the activity of the 
ERK, STAT1 or STAT3 signaling pathways following stimulation with IL-21 in either CMs or 
CFs (data not shown). 
IL-21 induces KC and MIP-2 expression through Akt/NF-kB or p38 MAPK/ NF-kB signaling  
Next, we examined whether the IL-21-dependent up-regulation of CXC chemokines is 
associated with IL-21-mediated activation of Akt, p38 MAPK and NF-kB signaling. CMs were 
pre-incubated with Akt inhibitor (LY294002 10 μM) or NF-kB inhibitor (BAY11-7082 10 μM), 
while CFs were pre-incubated with p38 MAPK inhibitor (SB203580 10 μM) or BAY11-7082. 
IL-21 was then added to the culture media, and the mRNA and protein expressions of KC and 
 14 
 
MIP-2 were assessed via real-time PCR and ELISA. The short-term incubation of the inhibitors 
had no effect on the basal levels of chemokine expressions in both CMs and CFs. Pre-incubation 
with either the Akt or NF-kB inhibitor abolished the IL-21-induced KC and MIP-2 mRNA 
expression in CMs, whereas KC and MIP-2 secretions in the presence of IL-21 were partially 
inhibited by either LY294002 or BAY11-7082 (Figure 7A and B). In CFs, the inhibition of either 
p38 MAPK or NF-kB significantly reduced the IL-21-mediated up-regulation of KC and MIP-2 
mRNA expression. Likewise, the IL-21-induced KC and MIP-2 secretions were partially 
inhibited by either SB203580 or BAY11-7082 (Figure 7C and D).             
Our previous time-course study indicated that the IL-21-induced phosphorylation of Akt 
and p38 MAPK preceded the phosphorylation of NF-kB in CMs and CFs, respectively. 
Therefore, we further assessed whether Akt or p38 MAPK act as upstream regulators. We found 
that a pre-incubation with Akt or p38 MAPK inhibitors partially reduced IL-21-induced 
activation of NF-kB signaling in CMs or CFs, respectively, suggesting that NF-kB activation 
may occur, at least in part, downstream of Akt and p38 MAPK signaling following IL-21 
exposure (Figure 7E and F).  
Discussion and conclusions 
The current study demonstrates a key role for IL-21 in myocardial injury in MIRI mice models. 
The data revealed that IL-21 was elevated during the acute phase of MIRI, and CD4+T may be a 
major source of IL-21 production. Treatment with exogenous IL-21 markedly exacerbated the 
myocardial injury, which was related to an increase in KC and MIP-2 expression and infiltration 
of neutrophils. Treatment with anti-IL-21 mAb induced the opposite effect. In vitro studies 
revealed that IL-21 could induce KC and MIP-2 expression, mainly through Akt/NF-kB 
signaling in CMs and p38 MAPK/NF-kB signaling in CFs. Furthermore, the neutrophil depletion 
study confirmed that IL-21 aggravated myocardial injury mainly via increased neutrophil 
infiltration. 
Emerging evidence has suggested that IL-21 mediates multiple types of tissue damage, and 
is an exacerbating factor in the pathogenesis of several inflammatory diseases, including 
inflammatory bowel disease, experimental autoimmune encephalomyelitis, rheumatoid arthritis, 
psoriasis, and type I diabetes (Di Fusco et al., 2014; Gharibi et al., 2016; Monteleone et al., 
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2009). Moreover, IL-21 has also been explored as a biomarker associated with the development 
of coronary artery disease (Ding et al., 2014) and left ventricular remodeling after acute 
myocardial infarction (Weir et al., 2012). However, the pathological role of IL-21 in the acute 
inflammatory response, especially during ischemia/reperfusion injury, remains largely unknown. 
In a mouse model of MIRI, we observed an early up-regulation of IL-21 and its functional 
receptor in the myocardium, supporting the hypothesis that IL-21 acts in the early stage of MIRI. 
Several immune cells have been reported to produce IL-21, including CD4+T cells, γδT cells, 
neutrophils and NKT cells (Coquet et al., 2007; Sutton et al., 2009; Puga et al., 2012; Clarkson 
et al., 2014).. Our study revealed that CD4+T cells mainly account for the production of IL-21 
during MIRI. We further demonstrated that neutralization of endogenous IL-21 attenuated 
myocardial injury; conversely, exogenous IL-21 administration increased infarct size and 
reduced cardiac function. This observation is consistent with prior studies showing that IL-21 
plays a pathogenic role in tissue I/R injury. Feng et al. have reported an increase of IL-21 
production at the initial stage of mouse liver IRI, which led to IL-17A production by NK cells, 
and promoted liver injury (Feng et al., 2012). More recently, IL-21 was found to be robustly 
up-regulated in mice within 24 h after cerebral reperfusion injury and to contribute to both 
immediate and delayed brain injury (Clarkson et al., 2014). 
Neutrophils are the most abundant leukocytes subset present during the first hours after 
ischemia reperfusion in the myocardium (Yan et al., 2013; Dreyer et al., 1991), and their 
infiltration is considered to be a critical event in MIRI, serving as the major source of reactive 
oxygen species and proteolytic enzymes (Vinten-Johansen, 2004). Previous evidence suggested 
that IL-21 may be involved in neutrophil recruitment and activation. IL-21 has been shown to 
indirectly induce the accumulation of neutrophils in a murine air-pouch model (Pelletier et al., 
2004) and enhance lung infiltration by neutrophils through up-regulation of KC expression 
(Spolski et al., 2012). Recent research by Takeda et al. indicates that IL-21 up-regulates the 
surface expression of CD11b and CD16 and enhances the phagocytic ability and ROS production 
of human peripheral blood neutrophils (Takeda et al., 2014). Despite the above-mentioned 
findings, whether IL-21 affects neutrophil recruitment in relation to tissue ischemic reperfusion 
injury had not yet been examined. Our in vivo study shows that IL-21 can induce myocardial 
neutrophil infiltration during the early stage of reperfusion through the induction of KC and 
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MIP-2 expression. Whereas, neutralization of endogenous IL-21 reduced the number of 
neutrophil infiltration and expression of KC and MIP-2 in myocardial tissue. Our in vitro study 
further confirmed that IL-21 has direct effects on CMs and CFs, inducing KC and MIP-2 
expression at both the mRNA and protein levels, and enhancing the migratory ability of 
neutrophils. 
In subsequent experiments, we investigated the signaling mechanisms underlying the 
IL-21-mediated effects. IL-21 has been previously reported to activate several signaling 
pathways, including JAK-STAT (primarily STAT1 and STAT3), ERK, p38 MAPK, PI3K/Akt, 
and NF-kB in different tissues and cell types (Brenne et al., 2002; Caruso et al., 2009; Caruso et 
al., 2007; Caruso et al., 2007; Pelletier et al., 2004; Wang et al., 2015; Xing et al., 2016). 
Moreover, these signaling pathways are also known to be involved in the processes associated 
with MIRI (Lopez-Neblina et al., 2006). Our in vivo study indicated that IL-21 activates p38 
MAPK and NF-kB signaling, which are both important in the production of various 
pro-inflammatory mediators, including cytokines, chemokines and adhesion molecules (Van der 
Heiden et al., 2010). At a cellular level, IL-21 induced Akt and, subsequently, NF-kB p65 
activation in CMs, while in CFs, IL-21 induced the phosphorylation of p38 MAPK, which 
preceded the activation of NF-kB p65. Because Akt signaling was slightly inhibited in CFs after 
IL-21 stimulation, the opposite effects of IL-21 on CMs and CFs may explain why the activation 
of Akt was not observed in the ischemic myocardium in vivo. 
NF-κB has been characterized as a critical transcriptional factor that regulates most 
chemokines at the level of transcription, and several signaling pathways are reported to regulate 
the upstream of NF-κB, including p38MAPK and PI3K/Akt. Previous reports indicated that 
up-regulation of CXC chemokines could be induced by NF-κB activation via the PI3K/Akt/IKK 
pathway in various cell types ( Lee et al., 2012; Li et al., 2003; Li et al., 2015; Lin et al., 2011). 
In the present study, the involvement of Akt/NF-kB or p38 MAPK/NF-kB signaling in 
IL-21-mediated chemokine expression was further confirmed by using relevant signaling 
inhibitors, and the results of this inhibition were consistent with previous evidence indicating 
that CXC chemokine expression is induced via the activation of p38 MAPK, PI3K/Akt and 
NF-kB signaling in different cellular contexts (Lafontant et al., 2006; Stephanou, 2002; Turner et 
al., 2011). However, it should be noted that although the inhibition of Akt and NF-kB signaling 
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could substantially suppress IL-21-induced KC/MIP-2 mRNA expression, it only reduced but did 
not abrogate IL-21-induced secretion of KC/MIP-2 in CMs. Likewise, the inhibition of p38 
MAPK and NF-kB signaling also partially inhibited the IL-21-induced secretion of KC/MIP-2 in 
CFs. These observations suggest that additional signaling pathways may be involved in the 
post-transcriptional regulations of these chemokines.  
In conclusion, our study presents novel evidence for a pathogenic role of IL-21 in MIRI, 
most likely by promoting cardiac neutrophil infiltration and chemokine expression. A proposed 
scheme of the effects of IL-21 on MIRI is provided in Figure 8. Thus, IL-21 could be a 
promising molecular target for ameliorating reperfusion injury.  
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Figure 1. IL-21 and IL-21R are elevated during the acute phase of myocardial 
ischemia/reperfusion injury (MIRI) and CD4+T cells are the major source of IL-21 in the 
ischemic myocardium. The time course of changes in the (A) mRNA and (B) protein expression 
of IL-21 in the myocardium following MIRI were measured by quantitative real-time PCR and 
western blotting, respectively (n=6 per group). The time course of changes in the (C) mRNA and 
(D) protein expression of IL-21R in the myocardium following MIRI were measured via 
quantitative real-time PCR and western blotting, respectively (n=6 per group). (E) The infiltrated 
IL-21+ leukocytes in myocardial I/R mice after 6 hours of reperfusion were analyzed by flow 
cytometry. CD45+ cells were isolated and restimulated. The IL-21+ CD45+ cells were further 
analyzed for CD3, CD4 and gdTCR expression to detect the cellular source of IL-21. The 
proportion of different IL-21-secreting cells in the IL-21+CD45+ cells were quantitatively 
analyzed (n=5 per group). *P <0.05 versus sham. 
Figure 2. IL-21 neutralization attenuates, whereas exogenous IL-21 aggravates, myocardial 
injury. (A) Representative images of left ventricular slices from different groups 1 day after 
reperfusion. The non-ischemic area is indicated in blue, the area at risk (AAR) in red, and the 
infarct area (I) in white. (B) Quantification of infarct size of myocardial tissues 1 day after 
reperfusion. (C) Serum cTnT was measured 1 day after reperfusion. (D) Representative M-mode 
echocardiographic images of the left ventricular 1 day after reperfusion. (E) Left ventricular 
ejection fraction (EF) and fractional shortening (FS) were measured via echocardiography 1 day 
after reperfusion. *P < 0.05 versus isotype; #P < 0.05 versus vehicle. Isotype, n=9; anti-IL-21, 
n=9; vehicle, n=11; IL-21, n=10. 
Figure 3. IL-21 increases the number of cardiac-infiltrating neutrophils and myocardial 
expression of keratinocyte-derived chemokine (KC) and macrophage inflammatory protein-2 
(MIP-2) following myocardial ischemia/reperfusion injury (MIRI), while anti-IL-21 mAb 
reduced cardiac-infiltrating neutrophils and the expression of KC and MIP-2. (A-D) The number, 
percentage and representative contour plots of CD11b+Gr-1+ neutrophils infiltrating the 
myocardium after 30 minutes of ischemia and 3 hours of reperfusion were analyzed via flow 
cytometry (n=5 per group). (E-F) The mRNA expression of KC, MIP-2, and LIX in the 
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myocardium after 30 minutes of ischemia followed by 30 minutes or 3 hours of reperfusion was 
analyzed via real-time PCR (n=5 per group). *P < 0.05 versus Sham; #P < 0.05 versus vehicle or 
isotype.  
Figure 4. IL-21 induces neutrophil migration and the expression of keratinocyte-derived 
chemokine (KC) and macrophage inflammatory protein-2 (MIP-2) in cardiomyocytes (CMs) and 
cardiac fibroblasts (CFs). (A) Neutrophil migration in the presence of conditioned supernatants 
from stimulated CMs (upper) and CFs (lower) was measured by transwell assay. The values were 
normalized relative to those of the medium from unstimulated CMs or CFs (control). (B) The 
mRNA expression of KC and MIP-2 in response to 1 h of stimulation with IL-21(100 ng·mL-1) in 
CMs (left) and CFs (right). (C) ELISA results of KC and MIP-2 levels in the supernatants of 
CMs (left) and CFs (right) stimulated by IL-21(100 ng·mL-1) for 24 h. H2O2 (100 μM) or TNF-α 
(5 ng·mL-1) served as positive controls for CMs and CFs, respectively. IL-21-alone control media 
was from unstimulated cells ‘spiked’ with IL-21. Data are representative of five independent 
experiments. *P < 0.05 versus control. 
Figure 5. Activation of the ERK, p38 MAPK, Akt, NF-kB, STAT1 and STAT3 signaling 
pathways in the myocardium after the administration of exogenous IL-21. (A) Representative 
western blots showing the activation of different signaling pathways 10 min after reperfusion in 
the myocardium after IL-21 administration. (B) Quantitative analysis of the levels of 
phospho-/total-ERK, p38 MAPK, Akt, NF-kB, STAT1 and STAT3 signaling pathways 10 min 
after reperfusion in different groups (n=6 per group). (C) Representative western blots showing 
the activation of different signaling pathways 30 min after reperfusion in the myocardium after 
IL-21 administration. (D) Quantitative analysis of the levels of phospho-/total-ERK, p38 MAPK, 
Akt, NF-kB, STAT1 and STAT3 signaling pathways 30 min after reperfusion in different groups 
(n=6 per group). *P < 0.05 versus sham; #P < 0.05 versus vehicle. 
Figure 6. Direct effects of IL-21 on the activation of Akt, p38 MAPK and NF-kB signaling in 
isolated cardiomyocytes (CMs) and cardiac fibroblasts (CFs). (A-B) Representative western 
blots showing the phospho-/total-Akt, p38 MAPK and NF-kB p65 levels in CMs and CFs 
unstimulated (control) or stimulated with IL-21 (100 ng·mL-1) for indicated durations. (C-D) 
Quantitative analysis of the phospho-/total- Akt, p38 MAPK and NF-kB p65 levels in CMs and 
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CFs. Data are representative of five independent experiments. *P < 0.05 versus control. 
Figure 7. IL-21-induced chemokine expression is Akt/NF-kB or p38 MAPK/NF-kB dependent. 
(A) Cardiomyocytes (CMs) were pre-treated for 1 h with an Akt inhibitor (LY294002, 10 μM) or 
an NF-kB inhibitor (BAY11-7082, 10 μM), followed by IL-21 (100 ng·mL-1) stimulation for 1 h. 
The expression of keratinocyte-derived chemokine (KC) and macrophage inflammatory 
protein-2 (MIP-2) was measured via real-time PCR. (B) CMs were pre-treated for 1 h with the 
indicated inhibitors, followed by IL-21 stimulation for 24 h. Concentrations of KC and MIP-2 in 
the culture media were measured via ELISA. (C) Cardiac fibroblasts (CFs) were pre-treated for 1 
h with a p38 MAPK inhibitor (SB203580, 10 μM) or an NF-kB inhibitor (BAY11-7082, 10 μM), 
followed by IL-21 (100 ng·mL-1) stimulation for 1 h. The expression of KC and MIP-2 was 
measured via real-time PCR. (D) CFs were pre-treated for 1 h with the indicated inhibitors, 
followed by IL-21 stimulation for 24 h. Concentrations of KC and MIP-2 in the culture media 
were measured via ELISA. (E) CMs were pre-treated with LY294002 and (F) CFs were 
pre-treated with SB203580 and then cells were stimulated with IL-21 or vehicle for 1 h. NF-kB 
p65 phosphorylation was analyzed via western blotting. Representative western blot images (left) 
and quantitative analyses (right) are shown. Data are representative of five independent 
experiments. *P < 0.05 versus control; #P < 0.05 versus IL-21. 
Figure 8. Schematic illustration of the IL-21-mediated effects on neutrophil recruitment in 
myocardial ischemia/reperfusion injury (MIRI). MIRI induces the up-regulation of IL-21 in the 
myocardium, which directly acts on cardiomyocytes (CMs) and cardiac fibroblasts (CFs) to 
promote the mRNA expression and production of keratinocyte-derived chemokine (KC) and 
macrophage inflammatory protein-2 (MIP-2) via the activation of Akt/NF-kB or p38 
MAPK/NF-kB signaling in CMs or CFs, respectively. KC and MIP-2 are potent neutrophil 
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Supplemental Table1 Primer sequences in qRT-PCR 
Gene    Forward (5’-3’) Reverse (5’-3’) 
IL-21     GGACCCTTGTCTGTCTGGTAG TGTGGAGCTGATAGAAGTTCAGG 
IL-21R    TGTCTCAATTCCTGTCCGATGA GCACGTAGTTGGAGGGTTCG 
KC  GCTGGGATTCACCTCAAGAA   CTTGGGGACACCTTTTAGCA   
MIP2 CGCCCAGACAGAAGTCATAG   TCCTCCTTTCCAGGTCAGTTA 
LIX GGTCCACAGTGCCCTACG GCGAGTGCATTCCGCTTA 





Figure S1 H2O2 induces IL-21R gene expression in CMs and TNF-α induces IL-21R gene 
expression in CFs. Serum-starved CMs were treated with H2O2 (100 μM) and CFs were treated 
with TNF-α (5 ng·mL-1) for different periods of time. The time course of changes in the mRNA 
expression of IL-21R was measured via quantitative real-time PCR. Data are shown as the means 





Figure S2 Depletion of neutrophils ameliorated the IL-21-induced myocardial ischemic injury. 
(A) The number of CD11b+Gr-1+ neutrophils infiltrating the myocardium after 30 minutes of 
ischemia and 3 hours of reperfusion was analyzed via flow cytometry. (B) Quantification of 
infarct size of myocardial tissues 1 day after reperfusion. (C) Serum cTnT was measured 1 day 
after reperfusion. (D) Left ventricular ejection fraction (EF) and fractional shortening (FS) were 


















Figure S3 Temporal changes of different signaling pathways in the ischemic myocardium at 
different time points after reperfusion. Quantitative analysis of the phospho-/total-ERK, Akt, p38 
MAPK, NF-kB p65, STAT1 and STAT3 levels in the myocardium at the indicated time points are 
shown (n=6 per group). * P < 0.05 versus control. 
 
 
